EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Designing and evaluating a new smart immunotoxins for targeting cancerous nerve cells

Shabnam Ensandoost, Aliakbar Haddad-Mashadrizeh

Journal of Cellular Immunotherapy · 2015

DOI: 10.1016/j.jocit.2015.10.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular Immunotherapy, 2015. Verfasst von Shabnam Ensandoost und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

miRNAs have been described as oncogenes or tumor suppressors and many of them are used for diagnosis and as prognostic or predictive tools.But till now, two challenges are remained that requires further study: (i) the safety profile of miRNAs and (ii) clinic delivery.Fig. 1.PubMed query for miRNAs and cancer (September 2015).

Zitieren

APA

Ensandoost, S., & Haddad-Mashadrizeh, A. (2015). Designing and evaluating a new smart immunotoxins for targeting cancerous nerve cells. Journal of Cellular Immunotherapy. https://doi.org/10.1016/j.jocit.2015.10.012

Vancouver

Ensandoost S, Haddad-Mashadrizeh A. Designing and evaluating a new smart immunotoxins for targeting cancerous nerve cells. Journal of Cellular Immunotherapy. 2015. doi:10.1016/j.jocit.2015.10.012

BibTeX
@article{Ensandoost2015,
  author = {Ensandoost, Shabnam and Haddad-Mashadrizeh, Aliakbar},
  title = {Designing and evaluating a new smart immunotoxins for targeting cancerous nerve cells},
  journal = {Journal of Cellular Immunotherapy},
  year = {2015},
  doi = {10.1016/j.jocit.2015.10.012}
}
Kostenlos starten →